Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
November 12, 2024 08:00 ET
|
Acuitive Technologies
Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.
Globus Medical Reports Third Quarter 2024 Results
November 05, 2024 16:15 ET
|
Globus Medical
AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended...
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 04, 2024 07:30 ET
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
October 15, 2024 16:30 ET
|
Globus Medical
AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended...
Angitia Biopharmaceuticals to Present Data on AGA2118 for Osteoporosis at ASBMR 2024
September 16, 2024 07:30 ET
|
Angitia Biopharmaceuticals
Angitia announces multiple presentations at ASBMR.
Accarent Health Announces Affiliation with Cleveland Clinic to Provide Bariatric, Orthopedic, and Spine Services
August 21, 2024 10:57 ET
|
Accarent Health
Baltimore, MD, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Accarent Health has announced a new affiliation with Cleveland Clinic, which is recognized in the United States and throughout the world for its...
Globus Medical Reports Second Quarter 2024 Results
August 06, 2024 16:15 ET
|
Globus Medical
AUDUBON, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30,...
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
July 17, 2024 08:30 ET
|
Globus Medical
AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food...
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
July 16, 2024 16:30 ET
|
Globus Medical
AUDUBON, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June...
IncludeHealth Partners with OrthoForum Value Network to Revolutionize Musculoskeletal Care
June 26, 2024 04:00 ET
|
IncludeHealth
Columbus, OH, June 26, 2024 (GLOBE NEWSWIRE) -- IncludeHealth, a leading provider of virtual physical therapy and patient data collection, is proud to announce its partnership with OrthoForum Value...